We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Point-of-Care Diagnostic Device Performs Several Tests from a Single Sample Preparation

By LabMedica International staff writers
Posted on 12 May 2015
A prototype model of a portable multipurpose point-of-care diagnostic analyzer was used in proof-of-principle studies that established the potential usefulness of this type of instrument.

Most instruments for point-of-care testing were designed for a single purpose such as measuring blood glucose or for home pregnancy detection, requiring clinics to purchase numerous devices to cover the range of diagnostic tests to be performed. More...
While these tests are simple to perform individually, each device often has a different sample preparation procedure that must be performed for each test. Having different sample preparation procedures for each diagnostic test increases the time to perform several tests, as samples must be prepared separately, and increases the chance of error due to improper sample preparation.

A new device, developed at Emory University (Atlanta, GA, USA) eliminates the problem of different preparation procedures by combining several point-of-care applications into a single, easy-to-use device with a common method of sample preparation.

The "AcµRay" system consists of a small diagnostic device that can be connected to a computer through a USB port. Diagnostic tests are performed by plugging a sensor into the device, then passing a blood sample through the detector. The attached computer analyzes and reports the results of the test. The sensors comprise a small microchip that can be coated with different antibodies that detect selected biomarkers. Biomarker binding to the antibodies on the chip changes its acoustic signature, which is detected by the detector and interpreted by the computer. Various diagnostics tests can be carried out by the AcµRay device by simply unplugging one sensor and plugging in a new one.

So far, a prototype of the AcµRay instrument has been built, and a proof-of-principle study was successfully carried out in which the acoustic sensor employed a biomarker for mesothelioma, a rare form of cancer linked to asbestos exposure.

Related Links:

Emory University



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Pipet Controller
Stripettor Pro
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.